LNB
TEVA icon

Ledyard National Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Ledyard National Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,023
Closed -$62K – 594
2018
Q4 		$62K Sell
4,023
-160
-4% -$3.28K 0.01% 382
2018
Q3 		$90K Buy
4,183
+160
+4% +$3.71K 0.01% 360
2018
Q2 		$98K Hold
4,023
– – 0.01% 359
2018
Q1 		$69K Buy
4,023
+3,823
+1,912% +$74.6K 0.01% 404
2017
Q4 		$4K Sell
200
-2,000
-91% -$30.1K ﹤0.01% 748
2017
Q3 		$39K Sell
2,200
-2,300
-51% -$51.8K 0.01% 475
2017
Q2 		$149K Buy
4,500
+1,475
+49% +$45.7K 0.02% 301
2017
Q1 		$97K Sell
3,025
-6,196
-67% -$211K 0.01% 349
2016
Q4 		$334K Sell
9,221
-4,848
-34% -$194K 0.06% 157
2016
Q3 		$647K Sell
14,069
-1,695
-11% -$88.4K 0.12% 121
2016
Q2 		$791K Sell
15,764
-1,255
-7% -$66.8K 0.14% 114
2016
Q1 		$911K Hold
17,019
– – 0.16% 111
2015
Q4 		$1.12M Sell
17,019
-2,055
-11% -$127K 0.2% 100
2015
Q3 		$1.08M Sell
19,074
-4,450
-19% -$289K 0.21% 101
2015
Q2 		$1.39M Sell
23,524
-5,380
-19% -$332K 0.24% 94
2015
Q1 		$1.8M Sell
28,904
-154,333
-84% -$8.97M 0.32% 87
2014
Q4 		$10.5M Sell
183,237
-4,020
-2% -$224K 1.94% 8
2014
Q3 		$10.1M Sell
187,257
-3,290
-2% -$174K 1.87% 10
2014
Q2 		$9.99M Sell
190,547
-2,915
-2% -$149K 1.67% 12
2014
Q1 		$10.2M Sell
193,462
-1,140
-0.6% -$52.7K 1.74% 12
2013
Q4 		$7.8M Buy
194,602
+13,231
+7% +$521K 1.3% 20
2013
Q3 		$6.85M Buy
181,371
+179,835
+11,708% +$7.02M 1.21% 24
2013
Q2 		$60K Buy
+1,536
New +$59.8K 0.01% 212

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ledyard National Bank's TEVA Position: Q1 2019 in Review

Ledyard National Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 4,023 shares — an estimated $62K sold.

Ledyard National Bank first reported a position in TEVA in Q2 2013 and held it in 23 quarters. The position peaked at $10.5M in Q4 2014. 521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Ledyard National Bank reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Ledyard National Bank sold 4,023 Teva Pharmaceuticals shares in Q1 2019, an estimated $62K.
  • Ledyard National Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • Ledyard National Bank's Teva Pharmaceuticals position peaked at $10.5M in Q4 2014.
  • 521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.